Diabetes complications

The relationship between shrunken pore syndrome and all-cause mortality in people with type 2 diabetes and normal renal function: the Fremantle Diabetes Study Phase II

DiabetologiaPublished Prospective cohort study

Authors' conclusion

A low eGFRcyst/eGFRcreat ratio is independently associated with mortality in type 2 diabetes, including in people without conventional markers of diabetic kidney disease. The presence of SPS may add clinical value to the risk assessment of people with type 2 diabetes regardless of renal status.

Study context

Population
Adults with T2D aged ≥17 years, Fremantle Diabetes Study Phase II; mean age 65.9 years, 51.8% male, median diabetes duration 9.0 years; subgroup with normal renal function (eGFRcreat ≥60 ml/min per 1.73 m² and urinary albumin/creatinine ratio <3 mg/mmol)of 1481 participants
Participants
1,466 adults
Exposure
eGFRcyst/eGFRcreat ratio <0.60 vs higher ratio
Outcome
All-cause mortality
Follow-up
10 years or until death
Methodological detailslongitudinal observational, community-based (Fremantle Diabetes Study Phase II)
  • Longitudinal observational
  • Community-based (Fremantle Diabetes Study Phase II)

Main finding

As reported in the abstract

10-year follow-up
Estimate (95% CI)P value
SPSvs Ratio ≥0.60most parsimonious Cox model
HR 1.56(1.07–2.29)
P = 0.021
eGFRcyst/eGFRcreat ratio, per 0.1 increasecontinuous variable
aHR 0.91(0.85–0.97)
P = 0.004
Deaths during follow-up
384 (26.2%)
Prevalence of eGFRcyst/eGFRcreat ratio <0.60 (shrunken pore syndrome (SPS))
10.4%

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)P value
All-cause mortality, subgroup with normal renal function (n=754) · 10-year follow-upIndependent association2.55 (1.34–4.84)P = 0.004
All-cause mortality, subgroup with normal renal function (n=754) — Deaths during follow-up
123 (16.3%)
All-cause mortality, subgroup with normal renal function (n=754) — eGFRcyst/eGFRcreat ratio <0.60
57 (7.6%)

Original publication

The relationship between shrunken pore syndrome and all-cause mortality in people with type 2 diabetes and normal renal function: the Fremantle Diabetes Study Phase II. Diabetologia. Published 21 April 2025. doi:10.1007/s00125-025-06430-6

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.